Anupam Rasayan India Limited

BSE: ANURAS543275ISIN INE930P01018

Commodities
Specialty Chemicals

BSE listing

Share price

₹1,205.65+26.15 (+2.22%)

as of 18 Sep 2026

52W high: ₹1,415.40
52W low: ₹1,047.40
Off 52W high: -14.82%
1M return: -1.43%
3M return: -5.77%
6M return: -3.70%
1Y return: +10.94%
20D avg volume: 5,015
50 DMA: ₹1,231.72
200 DMA: ₹1,277.19

Key ratios Consolidated

Market cap: ₹13,726 Cr
Current price: ₹1,205.65
52W high / low: ₹1,415.40 / ₹1,047.40
Face value: ₹10.00
P/E: 61.02
P/B: —
EPS (TTM): ₹19.76
Book value / share: —
ROE: —
ROCE: 7.50%
Operating margin: —
Net margin: —
Debt / equity: 0.39
Net debt: ₹1,437 Cr
Interest cover: 2.71
Dividend yield: 0.12%
Dividend / share (TTM): ₹1.50
Payout: 7.59%
Cash conversion cycle: 276.0 days

About

In plain English

Anupam Rasayan is a specialty chemical manufacturer that makes the complex, high-value ingredients used in things like crop protection products (insecticides, fungicides, herbicides), medicines, personal care items (like anti-bacterial creams and UV protection), and high-performance materials for defense, aerospace, and electronics. For example, they produce the key starting materials for blockbuster drugs and the specialty monomers used in semiconductors. Their customers are major global companies like Syngenta, Sumitomo Chemical, and ADAMA, as well as other blue-chip multinationals. They make money by manufacturing and selling these intermediates and active ingredients, often through long-term contracts, and by offering custom synthesis services to these large clients.

AI-generated summary, written from the company's own filings and disclosures. Every figure elsewhere on this page comes from exchange data, not from a model. See our editorial standards. Generated 15 Jul 2026.

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	654.98	635.78	512.45	731.40	485.83	500.16	390.14	293.96	254.20	401.01	295.52	392.15
	12.56	3.37	2.10	7.79	4.91	5.54	3.55	1.93	6.07	12.04	2.38	3.46
	597.86	583.08	454.60	663.65	427.89	417.58	327.09	261.88	244.05	355.14	262.00	324.94
	353.89	385.76	269.70	425.35	361.20	282.97	272.68	198.54	182.73	128.85	147.29	187.23
	0.00	0.00	0.00	1.96	1.96	0.00	—	—	—	—	—	—
	64.88	30.82	18.05	17.37	20.33	18.41	20.09	18.15	16.96	17.00	21.03	18.50
	49.19	41.91	35.16	35.98	35.66	31.22	31.96	26.66	22.38	26.07	25.13	20.43
	56.06	42.68	34.47	32.07	30.68	30.66	29.30	21.68	20.65	20.75	20.43	19.85
	143.03	136.18	93.33	103.92	97.35	99.78	89.13	87.22	81.86	103.44	94.47	103.63
	69.68	56.07	59.95	75.54	62.85	88.12	59.50	34.02	16.22	57.91	35.90	70.67
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	69.68	56.07	59.95	75.54	62.85	88.12	59.50	34.02	16.22	57.91	35.90	70.67
	18.47	0.07	-0.64	18.38	14.39	25.19	5.29	3.40	4.01	17.44	9.88	21.97
	51.22	56.00	60.59	57.15	48.46	62.93	54.21	30.62	12.21	40.47	26.02	48.69
	3.39	3.75	4.31	3.93	3.10	4.06	2.57	1.51	0.36	2.81	1.70	3.78
Key metrics
	174.93	140.66	129.58	143.59	129.19	150.00	120.76	82.36	59.25	104.73	81.46	110.95
	26.70%	22.10%	25.30%	19.60%	26.60%	30.00%	31.00%	28.00%	23.30%	26.10%	27.60%	28.30%
	7.80%	8.80%	11.80%	7.80%	10.00%	12.60%	13.90%	10.40%	4.80%	10.10%	8.80%	12.40%
	—	1.80%	—	3.00%	—	3.40%	—	—	—	—	—	—
	34.80%	27.10%	31.40%	148.80%	91.10%	24.70%	32.00%	-25.00%	—	—	—	—
	5.70%	-11.00%	11.80%	86.60%	296.90%	55.50%	108.30%	-37.10%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21
Income statement
	2,535	2,365	1,437	1,475	1,602	1,066	810.89
	25.82	18.17	11.48	30.25	8.57	15.11	26.43
	2,299	2,129	1,251	1,264	1,304	859.90	737.32
	1,435	1,442	936.92	693.14	767.59	691.70	469.36
	1.96	0.00	0.00	—	—	—	—
	131.12	86.58	73.61	75.14	68.90	48.50	32.44
	162.24	148.71	112.22	89.43	62.66	30.83	68.54
	165.28	139.90	102.28	79.70	71.08	60.12	51.65
	476.46	430.78	358.00	404.88	398.09	350.56	245.72
	261.24	254.40	197.85	241.77	306.19	221.20	100.00
	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	261.24	254.40	197.85	241.77	306.19	221.20	100.00
	36.28	32.20	37.88	74.33	90.82	69.68	29.71
	224.96	222.20	159.97	167.43	216.85	152.18	70.30
	15.38	15.09	8.50	11.89	20.91	15.22	8.56
Key metrics
	588.76	543.01	412.35	410.90	439.93	312.15	220.19
	23.23%	23.00%	28.70%	27.90%	27.50%	29.30%	27.20%
	8.88%	9.40%	11.10%	11.40%	13.50%	14.30%	8.70%
	—	7.50%	9.00%	—	—	—	—
	—	64.60%	-2.60%	-7.90%	50.30%	31.50%	—
	—	38.90%	-4.50%	-22.80%	42.50%	116.50%	—
	—	-220.83	-440.04	—	—	—	—
	—	1.50	-0.19	—	—	—	—
	—	0.39	0.43	—	—	—	—
	—	1,437	1,205	—	—	—	—
	—	276.0	408.7	—	—	—	—
Balance sheet
	—	8,013	5,269	—	—	—	—
	—	3,728	2,573	—	—	—	—
	—	378.07	113.05	—	—	—	—
	—	959.38	733.76	—	—	—	—
	—	1,775	1,452	—	—	—	—
	—	569.76	245.03	—	—	—	—
	—	2,980	2,038	—	—	—	—
	—	945.53	576.38	—	—	—	—
	—	2,615	1,808	—	—	—	—
	—	1,815	1,318	—	—	—	—
	—	1,304	1,147	—	—	—	—
	—	510.85	171.18	—	—	—	—
	—	4,630	3,082	—	—	—	—
Cash flow
	—	334.33	-30.12	—	—	—	—
	—	-820.24	-329.91	—	—	—	—
	—	620.93	223.27	—	—	—	—
	—	555.16	409.92	—	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	328.81	370.58	401.37	587.93	315.69	330.67	212.09	190.67	163.95	308.46	214.71	317.07
	6.08	2.49	4.95	7.70	4.83	5.32	2.89	3.85	5.58	11.09	1.43	3.53
	293.19	338.39	363.58	541.03	281.60	280.87	196.22	183.68	167.53	277.69	194.46	264.03
	194.02	199.22	244.41	323.38	257.32	189.77	174.56	151.29	132.74	77.04	102.24	148.79
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	12.09	11.24	10.88	10.63	12.31	11.67	14.31	12.26	11.61	12.18	15.20	13.49
	42.09	37.37	33.59	34.75	33.72	29.13	30.50	25.35	21.83	24.60	25.04	20.18
	31.70	31.42	29.30	27.64	26.44	26.57	25.79	19.78	18.63	18.50	18.43	17.94
	68.67	82.04	63.10	72.08	67.98	70.86	61.60	66.53	63.58	87.08	78.39	88.69
	41.70	34.67	42.74	54.59	38.92	55.12	12.97	10.85	2.00	41.85	21.68	56.58
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	41.70	34.67	42.74	54.59	38.92	55.12	12.97	10.85	2.00	41.85	21.68	56.58
	9.69	-7.71	-5.18	13.19	9.23	17.03	6.16	3.18	0.59	13.54	6.35	17.83
	32.01	42.38	47.92	41.40	29.69	38.09	19.14	14.03	1.42	28.32	15.34	38.75
	2.81	3.73	4.22	3.67	2.70	3.47	1.74	1.28	0.13	2.58	1.42	3.60
Key metrics
	115.49	103.46	105.63	116.98	99.08	110.82	69.26	55.98	42.46	84.95	65.15	94.70
	35.10%	27.90%	26.30%	19.90%	31.40%	33.50%	32.70%	29.40%	25.90%	27.50%	30.30%	29.90%
	9.70%	11.40%	11.90%	7.00%	9.40%	11.50%	9.00%	7.40%	0.90%	9.20%	7.10%	12.20%
	—	1.90%	—	2.60%	—	2.70%	—	—	—	—	—	—
	4.20%	12.10%	89.20%	208.30%	92.60%	7.20%	-1.20%	-39.90%	—	—	—	—
	7.80%	11.30%	150.40%	195.10%	1,990.80%	34.50%	24.80%	-63.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21
Income statement
	1,689	1,676	895.90	1,129	1,284	1,066	810.89
	21.22	19.96	13.35	25.91	2.19	15.11	26.43
	1,536	1,525	828.29	980.96	1,044	860.93	737.89
	961.03	1,024	648.36	505.55	576.63	692.98	470.41
	0.00	0.00	0.00	—	—	—	—
	44.84	45.08	49.85	54.48	54.47	48.50	32.44
	147.80	139.44	106.81	87.40	61.86	30.83	68.54
	120.06	114.80	90.77	71.87	65.56	60.12	51.65
	285.89	285.20	262.57	340.78	348.81	350.30	245.56
	173.70	170.93	80.95	173.65	242.24	220.18	99.42
	0.00	0.00	0.00	—	—	—	—
	173.70	170.93	80.95	173.65	242.24	220.18	99.42
	9.99	9.53	8.28	56.35	73.71	69.41	29.50
	163.71	161.40	72.67	117.29	168.53	150.78	69.92
	14.43	14.32	6.62	10.85	16.25	15.08	8.51
Key metrics
	441.56	425.17	278.53	332.92	369.66	311.13	219.61
	26.15%	25.40%	31.10%	29.50%	28.80%	29.20%	27.10%
	9.69%	9.60%	8.10%	10.40%	13.10%	14.10%	8.60%
	—	8.30%	5.90%	—	—	—	—
	—	87.00%	-20.60%	-12.10%	20.50%	31.50%	—
	—	122.10%	-38.00%	-30.40%	11.80%	115.60%	—
	—	-169.64	-371.74	—	—	—	—
	—	1.70	-0.89	—	—	—	—
	—	0.47	0.45	—	—	—	—
	—	1,467	1,186	—	—	—	—
	—	316.9	593.6	—	—	—	—
Balance sheet
	—	5,898	4,881	—	—	—	—
	—	2,816	2,333	—	—	—	—
	—	56.17	81.81	—	—	—	—
	—	919.96	652.06	—	—	—	—
	—	1,398	1,355	—	—	—	—
	—	431.61	231.20	—	—	—	—
	—	2,163	1,826	—	—	—	—
	—	863.22	549.87	—	—	—	—
	—	2,178	1,709	—	—	—	—
	—	1,523	1,268	—	—	—	—
	—	1,206	1,104	—	—	—	—
	—	317.32	164.30	—	—	—	—
	—	3,235	2,805	—	—	—	—
Cash flow
	—	274.17	-64.82	—	—	—	—
	—	-655.85	-286.33	—	—	—	—
	—	356.04	191.55	—	—	—	—
	—	443.81	306.92	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +9.27%
Sales CAGR 5Y: +15.62%
Sales CAGR 10Y: —
Profit CAGR 3Y: -1.43%
Profit CAGR 5Y: +18.21%
Profit CAGR 10Y: —
Sales YoY (TTM): +60.96%
Profit YoY (TTM): +62.17%

Consolidated

Sales CAGR 3Y: +13.87%
Sales CAGR 5Y: +23.88%
Sales CAGR 10Y: —
Profit CAGR 3Y: +0.82%
Profit CAGR 5Y: +25.88%
Profit CAGR 10Y: —
Sales YoY (TTM): +51.76%
Profit YoY (TTM): +14.65%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 59.08%

Holder	Type	Holding	Previous	Change
Kiran Pallavi Investments LLC	Promoter	31.80%	—	—
Milan R Thakkar	Public	14.41%	—	—
Anand Sureshbhai Desai	Promoter	9.73%	—	—
Shraddha Anand Desai	Promoter Group	6.84%	—	—
Rehash Industrial And Resins Chemicals Pvt Ltd	Promoter	6.34%	—	—
Jayeshkumar Virendrabhai Patel	Public	3.64%	—	—
Mona Anandbhai Desai	Promoter	3.64%	—	—
Jainam Broking Limited	Public	3.28%	—	—
Vikasa India Eif I Fund	Public	2.31%	—	—
Thakkar Nileshkumar Farshuram (Huf)	Public	1.54%	—	—
Zeal Global Opportunities Fund	Public	1.49%	—	—
M7 Global Fund Pcc - Cell Dewcap Fund	Public	1.48%	—	—
Panna Divyesh Vaidya	Promoter Group	0.55%	—	—
Ushma Deven Mehta	Promoter	0.18%	—	—
Meenaben Bharatbhai Desai	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

The Board of Directors of the Company at its meeting held on September 19, 2026, has considered and approved the issuance of Non-Convertible Debentures on a private placement basis.19 Sep 2026 · Company Update / Issue of Securities
The Board of Directors of the Company at its meeting held on September 19, 2026, has considered and approved the issuance of Non-Convertible Debentures on a private placement basis.19 Sep 2026 · Board Meeting / Outcome of Board Meeting
Outcome of Board Meeting - Approval for execution of certain security documents.17 Sep 2026 · Others / Outcome without intimation
Anupam Rasayan India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2026 ,inter alia, to consider and approve the fund raising of up ....16 Sep 2026 · Board Meeting / Board Meeting
Acquisition of equity shares in Tanfac Industries Limited pursuant to preferential issue.9 Sep 2026 · Company Update / Acquisition
Submission of Newspaper Advertisement regarding 23rd Annual General Meeting of the members of the Company.9 Sep 2026 · Company Update / Newspaper Publication
Submission of Integrated Annual Report for the financial year 2025-26.8 Sep 2026 · Others / Reg. 34 (1) Annual Report
Submission of Business Responsibility and Sustainability Report for the year 2025-26.8 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
23rd Annual General Meeting of the Company is scheduled to be held on Wednesday, September 30, 2026 at 09:30 a.m. IST.8 Sep 2026 · AGM/EGM / AGM
The Board of Directors of the Company at its meeting held on September 07, 2026, has approved the acquisition of equity shares in Tanfac Industries Limited pursuant to a preferential issue.7 Sep 2026 · Company Update / Acquisition
The Board of Directors of the Company at its meeting held on September 07, 2026, has considered and approved the appointment of Ms. Hetvi Vyas as Chief Deputy Financial Officer and Key ....7 Sep 2026 · Company Update / Change in Management
The Board of Directors of the Company at its meeting held on September 07, 2026, has approved and fixed the record date as Friday, September 18, 2026, for the payment of final dividend ....7 Sep 2026 · Corp. Action / Record Date
Outcome of Board Meeting held on September 07, 2026.7 Sep 2026 · Others / Outcome without intimation
Intimation of Press Release titled "Anupam Rasayan secures chemical supply contract with a Global Industrial Major, paving the way for a Long-Term Six-year Partnership"5 Sep 2026 · Company Update / Press Release / Media Release
Submission of Newspaper Advertisement clippings pertaining to Post Offer Advertisement.1 Sep 2026 · Company Update / Newspaper Publication
The credit rating agency Crisil Ratings Limited has continued its ratings on the bank facilities and non-convertible debentures of the Company.31 Aug 2026 · Company Update / Credit Rating
Submission of transcript of earnings call on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.20 Aug 2026 · Company Update / Earnings Call Transcript
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Anand Sureshbhai Desai17 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Submission of newspaper advertisement clippings pertaining to the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 202615 Aug 2026 · Company Update / Newspaper Publication
Submission of Audio Recording of Earnings Call pertaining to the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.14 Aug 2026 · Company Update / Analyst / Investor Meet
Investor Presentation regarding Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.14 Aug 2026 · Company Update / Investor Presentation
Press Release regarding Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.14 Aug 2026 · Company Update / Press Release / Media Release
The Board of Directors at its meeting held on August 14, 2026 has considered and approved the unaudited financial results (standalone & consolidated) of the company for the quarter ended ....14 Aug 2026 · Result / Financial Results
The Board of Directors at its meeting held on August 14, 2026 has considered and approved the appointment of Mr. Ravi Desai as Chief Operating Officer of the Company with effect from August 14, 2026.14 Aug 2026 · Company Update / Change in Management
The Board of Directors at its meeting held today i.e. August 14, 2026, has inter-alia, considered and approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ....14 Aug 2026 · Board Meeting / Outcome of Board Meeting
Nomination and Remuneration Committee of the Board at its meeting held on August 13, 2026, has approved the allotment of 1531 equity shares under ESOP Scheme.13 Aug 2026 · Company Update / Allotment of ESOP / ESPS
Intimation of the Earnings Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026, scheduled to be held on Friday, August 14, 2026, at ....11 Aug 2026 · Company Update / Analyst / Investor Meet
Anupam Rasayan India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....10 Aug 2026 · Board Meeting / Board Meeting
Submission of newspaper advertisement clippings pertaining to the Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement27 Jul 2026 · Company Update / Newspaper Publication
Submission of Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shareholders, by the Company together with PAC21 Jul 2026 · Company Update / General
Submission of copy of newspaper advertisement clippings pertaining to the Addendum to the Public Announcement, Detailed Public Statement and Draft Letter of Offer.18 Jul 2026 · Company Update / Newspaper Publication
Acquisition of shares17 Jul 2026 · Company Update / Acquisition
Press Release Intimation titled "Anupam Rasayan signs Letter of Intent with BASQUEVOLT, S.A. for the potential long-term supply of a specialty chemical product worth ?300 Mn.15 Jul 2026 · Company Update / Press Release / Media Release
Confirmation Certificate of Non-Applicability of Reg. 74(5) of SEBI (DP) Regulations.7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Trading Window shall remain closed from Wednesday, July 01, 2026 till the end of 48 hours after the declaration of the Unaudited Financial Results (Standalone and Consolidated) of the ....25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Press Release titled "Anupam Rasayan India Limited becomes the first company in the world to commercialise ETFA (Ethyl trifluoroacetate) using flow chemistry"11 Jun 2026 · Company Update / Press Release / Media Release
Pursuant to Regulation 30 of the SEBI Listing Regulations, please find attached Draft Letter of Offer filed by the Manager to the Offer with SEBI yesterday, relating to the mandatory open ....9 Jun 2026 · Company Update / General
Intimation of schedule of Investor Meet to be held on June 09, 20264 Jun 2026 · Company Update / Analyst / Investor Meet
The credit rating agency, India Ratings and Research (Ind-Ra) has updated the credit rating of the Company3 Jun 2026 · Company Update / Credit Rating
The credit rating agency CRISIL Ratings Limited has updated credit rating of the Company.3 Jun 2026 · Company Update / Credit Rating

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 1.5000	18 Sep 2026	18 Sep 2026	—
Interim Dividend - Rs. - 0.7500	21 Jul 2025	21 Jul 2025	—
Final Dividend - Rs. - 0.7500	17 Sep 2024	18 Sep 2024	—